Clinical Trials Browser

Phase 1/2 × Terminated × Capecitabine × Clear all

Neoplasm Metastasis

Pancreatic Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms, Colorectal Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Head and Neck Neoplasms, Neoplasm Metastasis

Pancreatic Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Pancreatic Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Adenocarcinoma, Neoplasms, Neoplasms, Unknown Primary

Brain Neoplasms, Breast Neoplasms

Colorectal Cancer Metastatic

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Pancreatic Neoplasms

Thyroid Neoplasms, Carcinoma, Medullary

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Clinical Trials

SYS-CAPLIOX

QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

QUILT-3.080: NANT Pancreatic Cancer Vaccine

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

Safety and Efficacy of Intra-Arterial and Intra-Tumoral Ad-p53 With Capecitabine (Xeloda) or Anti-PD-1 in Liver Metastases of Solid Tumors and Recurrent Head and Neck Squamous Cell Cancer

Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma

Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics

NivoPlus

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer

E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously Untreated Gastric Cancer

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Phase 1b/2 Study of BKM120 Plus Trastuzumab in Patients With HER2-positive Breast Cancer

AMOR

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

IXO+A

Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer

Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer